Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The subjects that meet the inclusion criteria of the study will be randomized preoperatively into three arms following a 1:1:1 ratio. During the intraoperative course one of three combinations of wound infiltration will be administered to subjects prior to the closure of the surgical incision. Subjects in Group I will receive a placebo of normal saline. Subjects in Group II will receive bupivacaine alone. Subjects in Group III will receive both bupivacaine and dexmedetomidine.
Epistemonikos ID: edc277cb1a083ee2377e558082885f42d03f2c1b
First added on: May 21, 2024